AMERIPRISE FINANCIAL INC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2023$62,272
-82.0%
22,400
-67.1%
0.00%
Q4 2022$345,000
+28.3%
67,995
+146.2%
0.00%
Q3 2021$269,000
-33.1%
27,615
-1.8%
0.00%
Q2 2021$402,000
-39.7%
28,135
+0.1%
0.00%
Q1 2021$667,00028,1000.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders